Booklet Labels Give Pharma and Medical Devices Room for Full Instructions Amid MHRA CE Mark Consultation

Booklet Labels Give Pharma and Medical Devices Room for Full Instructions Amid MHRA CE Mark Consultation

Regulatory expectations for pharmaceutical and medical device labelling are evolving, with the MHRA placing greater emphasis on traceability, transparency, and pre-market documentation. As part of ongoing consultations around CE marking and post-Brexit frameworks, many products now require significantly more on-pack information than in previous years.

This includes detailed instructions for use, multilingual warnings, Unique Device Identification (UDI) data, and expanded traceability information. For products with limited packaging space, such as vials, syringes, and diagnostic kits, meeting these requirements using traditional labels is no longer practical. Booklet labels have therefore become the standard solution across much of the sector.

How Booklet Labels Solve the Space Challenge

Booklet labels provide multiple pages of protected content while maintaining a compact footprint on the primary pack. The outer layer carries essential product identifiers, while the inner pages hold detailed instructions, safety information, and regulatory data in a structured and readable format.

This approach allows manufacturers to meet complex labelling requirements without overcrowding the visible surface of the product. It also improves usability for healthcare professionals, who need clear and accessible information in high-pressure environments.

Technical Advantages for Medical Applications

Medical-grade booklet labels are engineered to perform under strict conditions. They use specialised materials that withstand sterilisation processes, temperature variations, and long-term storage without degrading or losing adhesion.

They can also integrate digital features such as QR codes or NFC chips, linking to electronic instructions for use (eIFU) or full technical documentation. This supports a hybrid approach to compliance, where critical information is available both on-pack and digitally.

In addition, the construction must ensure that opening and resealing the booklet does not compromise sterility or product integrity, which is a key consideration in medical environments.

Evidence Required and Practical Next Steps

Regulators and procurement teams now expect comprehensive technical files that go beyond basic labelling. This includes documentation covering MHRA traceability requirements, food-contact material (FCM) migration data where relevant, and formal Declarations of Compliance.

Manufacturers should begin by auditing their current labelling against updated regulatory expectations, identifying where additional space or functionality is required. Working with an experienced converter allows for the development of booklet label designs that integrate with existing packaging lines and meet validation requirements.

Testing and verification should be completed before full rollout, including checks for durability, readability, and compatibility with sterilisation processes.

If you manufacture or supply pharmaceutical or medical device products, booklet labels provide a reliable way to meet evolving requirements while maintaining usability. For specialist medical-grade booklet label solutions designed for 2026 compliance, visit bookletlabels.co.uk.